$37.21
-0.84 (-2.21%)
BioMarin Pharmaceutical, Inc. (NASDAQ:BMRN)
CAPS Rating:
The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.
The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.